summary
Introduced
01/28/2021
01/28/2021
In Committee
01/28/2021
01/28/2021
Crossed Over
Passed
Dead
01/03/2023
01/03/2023
Introduced Session
117th Congress
Bill Summary
A BILL To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.
AI Summary
This bill, titled the "End Taxpayer Subsidies for Drug Ads Act," proposes to amend the Internal Revenue Code to disallow the deduction for expenses related to direct-to-consumer advertising of prescription drugs. Specifically, it would prohibit companies from deducting the costs of advertising prescription drugs directly to the general public through various media channels, such as print, broadcast, and digital platforms. The bill aims to eliminate the tax subsidy for these types of pharmaceutical advertisements, which are seen by some as contributing to the high costs of prescription drugs.
Committee Categories
Budget and Finance
Sponsors (23)
Jeanne Shaheen (D)*,
Tammy Baldwin (D),
Michael Bennet (D),
Richard Blumenthal (D),
Sherrod Brown (D),
Dick Durbin (D),
Dianne Feinstein (D),
Kirsten Gillibrand (D),
Maggie Hassan (D),
Mazie Hirono (D),
Tim Kaine (D),
Angus King (I),
Amy Klobuchar (D),
Patrick Leahy (D),
Joe Manchin (I),
Chris Murphy (D),
Jack Reed (D),
Bernie Sanders (I),
Brian Schatz (D),
Tina Smith (D),
Chris Van Hollen (D),
Elizabeth Warren (D),
Sheldon Whitehouse (D),
Last Action
Read twice and referred to the Committee on Finance. (on 01/28/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/117th-congress/senate-bill/141/all-info |
| BillText | https://www.congress.gov/117/bills/s141/BILLS-117s141is.pdf |
| Bill | https://www.congress.gov/117/bills/s141/BILLS-117s141is.pdf.pdf |
Loading...